Simultaneous positron emission tomography and MRI (PET/MRI) is a technology that
combines the anatomic and quantitative strengths of MR imaging with physiologic …

Over the past decade, the growing interest in targeted lung cancer therapy has guided
researchers toward the cutting edge of controlled drug delivery, particularly magnetic …

The role of MRI differs considerably between the three main groups of hematological
malignancies: lymphoma, leukemia, and myeloma. In myeloma, whole‐body MRI (WB‐MRI) …

Imaging is fundamental to diagnosis and management of pediatric patients with cancer and
cancer predisposition syndromes (CPSs). Whole-body MRI has emerged as a versatile tool …

The 6th annual meeting to address key issues in positron emission tomography
(PET)/magnetic resonance imaging (MRI) was held again in Tübingen, Germany, from …

OBJECTIVE. Fluorine-18-labeled FDG PET/CT and MRI are current imaging standards for
staging and assessing tumor response and recurrence of pediatric extracranial solid tumors …

CT, MRI, and FDG PET/CT play major roles in the diagnosis, staging, treatment planning,
and surveillance of head and neck cancers. Nonetheless, an evolving understanding of …

Integrated PET/MRI has shown significant clinical value for staging and restaging of children
with cancer by providing functional and anatomic tumor evaluation with a 1-stop imaging test …

Complete resection is the treatment of choice for most pediatric brain tumors, but early
postoperative MRI for detection of residual tumor may be misleading because of MRI signal …

Objectives To compare the diagnostic accuracy of 2-[18F] fluoro-2-deoxy-d-glucose-
enhanced positron emission tomography (2-[18F] FDG-PET) and diffusion-weighted …